Value proposition

Built for Better Health

- Get treatment for Pain management and Mental Health here: https://treat-it.clinic
- See a GP Online here: https://thegpservice.co.uk
- Shop Kanabo here: https://kanabo.store


Kanabo Group plc (LSE:KNB) is a digital health company committed to transforming patient care through its innovative technology platform and specialised treatment offerings. Since its inception, Kanabo has been focused on researching, developing, and commercialising regulated medicinal cannabis-derived formulations and therapeutic inhalation devices.

Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. Leveraging its telehealth capabilities, in 2023, Kanabo launched Treat It, an online clinic focused on chronic pain management that provides patients with medical cannabis treatments.

With its two complementary business divisions, Kanabo has established itself as an end-to-end digital health provider, offering telehealth consultations, prescriptions, alongside the delivery of tailored treatments.

The Company’s partially owned subsidiary, Kanabo Agritec Ltd, is a cultivation consultancy supporting cannabis businesses in developing new farms through infrastructural, research, and product guidance. These farms deliver high-quality raw materials for Kanabo’s formulas and product line.

At Kanabo Group Plc, we are dedicated to providing patients with the highest quality medical treatments and more accessible healthcare experiences.


Cannabis, Medical R&D, THC, DDS, Drug Delivery System, Medical Device, Vaporisation, MDR, Medical Cannabis, Healthtech, and Telehealth